Histoplasma Immunodiffusion (ID) Antigen; The IFU labeling is for multiple products which include...
FDA Device Recall #Z-2301-2020 — Class II — November 4, 2019
Recall Summary
| Recall Number | Z-2301-2020 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 4, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Immuno-Mycologics, Inc |
| Location | Norman, OK |
| Product Type | Devices |
| Quantity | 155 vials |
Product Description
Histoplasma Immunodiffusion (ID) Antigen; The IFU labeling is for multiple products which included Fungal Antigens, Positive Controls and ID Plates,and Immunodiffusion (ID) Plates for use in the ID Test, Histoplasma ID Antigen
Reason for Recall
False positive results due to potential contamination of reagent.
Distribution Pattern
Worldwide distribution - US Nationwide distribution including in the states of AZ, CA, FL, IL, IN, MI, MN, NY,TX, UT, VA, WI and the countries of France, Spain, Hong Kong, United Kingdom.
Lot / Code Information
Lot number L106909; UDI # (01) 00816387020391 (17) 220610(10)L106909
Other Recalls from Immuno-Mycologics, Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1389-2025 | Class II | Candida ID Antigen, REAG, AG, REF C50110, Vol 1... | Feb 10, 2025 |
| Z-0545-2022 | Class II | CRYPTOCOCCAL ANTIGEN LATERAL FLOW ASSAY, IMMY, ... | Jan 3, 2022 |
| Z-2409-2018 | Class II | Cryptococcal Antigen Lateral Flow Assay (CrAg L... | Mar 30, 2018 |
| Z-1109-2017 | Class II | Cryptococcal Antigen Lateral Flow Assay (CrAg L... | Dec 27, 2016 |
| Z-2040-2016 | Class II | Histoplasma Yeast Complement Fixation Antigen D... | May 9, 2016 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.